https://www.biospace.com/mirati-therapeutics-announces-proposed-public-offering-of-common-stock-nov-09-2021
Mirati Therapeutics, Inc. a clinical-stage oncology company, announced that it intends to offer and sell in an underwritten public offering $500 million of...
mirati therapeuticspublic offeringcommon stockannouncesproposed
https://www.devdiscourse.com/news?tag=Mirati%20Therapeutics
Latest News on Mirati Therapeutics, Read more information on Mirati Therapeutics
mirati therapeuticsnews